Ascension Asset Management’s Bio-Techne TECH Stock Holding History

Ascension Asset Management’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$1.26M	Hold	17,552	–	–	0.66%	57
2024 Q1	$1.24M	Buy	+17,552	New	+$1.26M	0.67%	60
2023 Q2	$1.43M	Buy	+17,552	New	+$1.41M	0.88%	44
2022 Q4	$1.47M	Sell	17,752 -100	-0.6%	-$7.94K	1.06%	41
2022 Q3	$1.26M	Hold	17,852	–	–	0.99%	45
2022 Q2	$1.55M	Buy	+17,852	New	+$1.67M	1.14%	40
2021 Q4	$2.32M	Sell	17,940 -260	-1%	-$31.9K	1.38%	30
2021 Q3	$2.21M	Hold	18,200	–	–	1.44%	22
2021 Q2	$2.05M	Sell	18,200 -200	-1%	-$21.1K	1.34%	27
2021 Q1	$1.76M	Buy	+18,400	New	+$1.68M	1.23%	33
2020 Q4	–	Sell	-19,200	Closed	-$1.19M	–	92
2020 Q3	$1.19M	Buy	+19,200	New	+$1.25M	0.95%	48
2020 Q1	$910K	Hold	19,200	–	–	0.95%	46
2019 Q4	$1.05M	Hold	19,200	–	–	0.91%	50
2019 Q3	$939K	Buy	+19,200	New	+$963K	0.87%	51

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

DDC

DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return

Ascension Asset Management's TECH Position: Q2 2024 in Review

Ascension Asset Management held its Bio-Techne (TECH) position steady in Q2 2024 at 17,552 shares worth $1.26M. The position accounts for 0.66% of the portfolio, ranked #57.

Ascension Asset Management first reported a position in TECH in Q3 2019 and has held it in 14 quarters since. The position peaked at $2.32M in Q4 2021. 571 funds tracked by Wall St. Rank hold TECH as of Q2 2024.

Ascension Asset Management held 17,552 shares of Bio-Techne worth $1.26M as of Q2 2024.
Ascension Asset Management left its Bio-Techne share count unchanged in Q2 2024.
Bio-Techne made up 0.66% of Ascension Asset Management's portfolio in Q2 2024, its #57 holding.
Ascension Asset Management first reported a position in Bio-Techne in Q3 2019 and has held it in 14 quarters since.
Ascension Asset Management's Bio-Techne position peaked at $2.32M in Q4 2021.
571 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2024.

Based on Ascension Asset Management's 13F filing for Q2 2024, filed 16 Aug 2024.